STOCKGURU PROFILE FOR MEDIZONE - CORPORATE WEB SITE
Medizone International, Inc.
Today I want to make two points. MZEI has enjoyed an excellent breakout recently and for good reason.
Current laboratory trials are taking place which include a hospital mock-up and hospital beta testing for AsepticSure(TM).
Initial sales are targeted to commence in the 4th quarter of 2009.
The most recent breakout suggests buyers are trying to get ahead of the curve and buy in before the announcement of actual sales.
Medizone puts out very few press releases — so it is important to read every line. Their releases cover multiple topics.
The most recent release indicates that initial sales will begin in the fourth quarter. I suspect this is the only notice we will get.
Medizone has a primary research and development platform for the Company as it proceeds towards commercialization of its AsepticSure™ product. This is a certified laboratory located in a Research Park located in Innovation Park, Queen’s University in Kingston, Ontario, Canada.
Do not wait to purchase this stock after they announce sales.
Medizone International, Inc. (MZEI.OB)
Post Office Box 742
Stinson Beach, CA 94970
Telephone: 415-868-0300
Email: operations@medizoneint.com
MZEI.OB Medizone International, Inc. is traded on the Over the Counter Bulletin Board (OTCBB) under the symbol MZEI.OB.
No comments:
Post a Comment